Developer docs
API playgroundTry for free, no card

Search company profiles

Mendaera

Full company profile

uuid0000a1i

Namestring
Mendaera
Legal namestring
Mendaera, Inc.
Websiteurl
mendaera.com
Company typeenum
Private
Founded yearint
2020
Descriptiontext

Mendaera, Inc. is a privately held healthcare technology company founded in 2020 in Silicon Valley and headquartered in San Mateo, California. The company develops the Focalist System, an FDA 510(k)-cleared handheld robotic platform that combines real-time ultrasound imaging with robotic needle positioning and continuous needle depth-tracking to enable precise, reproducible needle placement for ultrasound-guided procedures. The system is positioned to address operator-dependent variability in procedures such as percutaneous nephrolithotomy (PCNL), biopsies, vascular access, and other needle-based interventions, with the stated intent of making precision more accessible across providers with varying skill levels.

Mendaera's commercialization strategy is built around direct enterprise sales to leading medical institutions. The company initiated a limited U.S. launch in 2025 with an initial focus in urology, anchored by early adopters including Mayo Clinic Arizona (where Dr. Karen Stern performed the world's first Focalist procedures) and M Health Fairview. Full commercialization is planned for 2026, with stated expansion into interventional radiology, pain management, and anesthesiology. The company's go-to-market is reinforced by an active presence at industry conferences (AUA, ATC, SUFU, WCET, LSI USA '26, MedTech Insight) and recognition on multiple industry lists (Bessemer Top 50 Physical AI, CB Insights Top 50 Digital Health, Fierce 15, Business Insider Top 12).

The business model combines hardware sales of the Focalist System with recurring instrumentation and disposables (including bundled Cook Medical EchoTip needles) and ongoing service and maintenance through a customer portal. Strategic technology integrations with Butterfly Network (Ultrasound-on-Chip imaging) and EchoNous (image-guided intervention) extend the platform's imaging ecosystem. As of the available data, the company is pre-scaled commercially, having raised approximately $97 million-plus across a 2023 round led by Lux Capital and a 2024 Series B led by Threshold Ventures, with leadership drawn from prior medical robotics exits including Auris Health (acquired by J&J for up to $5.8 billion) and Intuitive Surgical.

Short descriptiontext

Mendaera is a San Mateo-based healthcare robotics company developing the FDA-cleared Focalist System, a handheld robotic platform combining real-time ultrasound imaging with robotic needle positioning for precise ultrasound-guided needle procedures, sold to hospitals initially targeting urology with planned expansion into interventional radiology and pain management.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersSan Mateo, United States
HQ citystring
San Mateo
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
handheld surgical robotics, ultrasound-guided procedures, medical robotics systems, needle placement devices, robotic imaging platforms
Industry4 codes
PRIMARYHLAHADAF
Surgical Robotics & Computer-Assisted Surgery Platforms
Healthcare & Life Sciences/Medical Devices & Diagnostics/Surgical Instruments, Endoscopy & OR Equipment
SECONDARYHLAHADAH
Intraoperative Imaging & Guidance (C-arms, O-arm, IOUS, fluorescence)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Surgical Instruments, Endoscopy & OR Equipment
SECONDARYHLAKAOAF
Endourology & Minimally Invasive Urologic Surgery
SECONDARYHLAHABAG
Interventional Radiology & Image-Guided Therapy Systems
Healthcare & Life Sciences/Medical Devices & Diagnostics/Medical Imaging & Radiology Equipment
NAICS code1 code
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
SIC code1 code
  • Surgical & Medical Instruments & Apparatus3841
Product category
Medical Robotics
Social media profiles1 record
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1Focalist System Hardware Sales
TypeHardware Sales
Description

Sale of the handheld robotic Focalist System to healthcare institutions. The company is preparing for commercial launch with initial focus on urology.

mendaera.com
2Instrumentation and Disposables
TypeHardware Sales
Description

Sale of compatible needles and instrumentation kits including Cook Medical's EchoTip technology integrated into Mendaera's offerings.

mendaera.com
3Service and Maintenance
TypeManaged Services
Description

Ongoing service and maintenance services provided through the customer portal for Focalist System users.

mendaera.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Technology or R&D, Supply Chain, Personnel, Marketing or Sales, Operations, Infrastructure
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 record
1Focalist
Description

Handheld robotic system for needle-based procedures combining real-time ultrasound imaging with robotic control for precise instrument placement during diagnostic and therapeutic procedures.

mendaera.com
Core offering1 text field

Mendaera designs, develops, and sells the Focalist System, a handheld robotic platform that combines real-time ultrasound imaging with robotic needle positioning to enable precise, reproducible needle placement during ultrasound-guided medical procedures. The company also offers compatible instrumentation (including integrated Cook Medical EchoTip needles) and post-sale service, training, and software updates through its customer portal, with initial commercial focus on urology and planned expansion into interventional radiology and pain management.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • Precise first-pass needle placement into ideal kidney location during PCNL procedures
+1 more record
Product overview1 text field

Mendaera offers the Focalist System, a single FDA-cleared handheld robotic platform that combines real-time ultrasound imaging with robotic needle positioning and advanced software. The system is designed to make precision needle-based procedures more accessible across healthcare settings. Mendaera generates revenue through medical device sales and provides配套 services including a customer portal with Instructions for Use, software release notes, maintenance information, and training materials. The company operates strategic partnerships with Butterfly Network (for ultrasound-on-chip technology integrated into the system) and Cook Medical (for bundled EchoTip needles in instrumentation offerings).

Product and service3 records
1Focalist System
CategoryHandheld Surgical Robotics
Description

FDA-cleared handheld robotic system that combines real-time ultrasound imaging with intuitive robotic control and touchscreen targeting to enable precise, reproducible needle placement for ultrasound-guided diagnostic and therapeutic procedures across multiple medical specialties, intended for use with pediatric and adult patients.

2Focalist Instrumentation and Disposables
CategoryMedical Device Instrumentation and Disposables
Description

Compatible needles and instrumentation kits sold alongside the Focalist System, including integrated Cook Medical EchoTip trocar needle technology, bundled to streamline setup and workflow for percutaneous needle-based procedures.

3Focalist Service, Maintenance, and Customer Portal
CategoryMedical Device Service and Support
Description

Ongoing service and maintenance offering delivered through a secure customer portal that provides Instructions for Use, software release notes, service information, training materials, and other support resources for Focalist System users at healthcare institutions.

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
1Cook Medical
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-04-23
Description

Collaboration to integrate Cook's EchoTip trocar needle technology with Mendaera's Focalist System for needle-based urological procedures. The partnership aims to create cutting-edge solutions for percutaneous procedures with fit-for-purpose disposables paired with robotics.

mendaera.com
Strategic tierMajorTypeTechnology or IntegrationAnnounced on2024-10-08
Description

Partnership to revolutionize image-guided intervention using EchoNous ultrasound technology integrated with Mendaera's robotic platform. Part of Mendaera's strategy to utilize advanced ultrasound-on-chip technology.

Strategic tierMajorTypeTechnology or IntegrationAnnounced on2023-01-01
Description

Commercial agreement established for use of Butterfly Network's Ultrasound-on-Chip technology in the Focalist System. Mendaera acquired telepresence technology and established this commercial partnership.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Market leader in robotic surgery with the da Vinci platform. While its systems are large, expensive, fixed installations focused on laparoscopic surgery, it represents the dominant incumbent Mendaera's leadership team previously competed against and that any handheld robotic entrant must displace or complement.

TypeBroad incumbent
Description

Acquired Auris Health for up to $5.8B and is developing the Ottava robotic surgery platform. Multiple Mendaera executives (DeFonzo, Davidson, Martinez) came directly from this organization, making J&J both a competitor and the most logical strategic acquirer of Mendaera's handheld platform.

TypeDirect peer
Description

Developer of the Versius surgical robotic system, a smaller, modular robotic platform competing in laparoscopic surgery. Like Mendaera, CMR is challenging the Intuitive paradigm with a more portable, lower-cost robotic architecture aimed at broader hospital adoption.

TypeDirect peer
Description

Developer of the Maestro handheld surgical robotics system, conceptually the closest peer to Mendaera. Both companies are pioneering handheld robotic form factors designed to assist surgeons in real-time, rather than full-sized fixed surgical robots.

TypeDirect peer
Description

Commercial-stage robotics company focused on urology with the AquaBeam/Aquablation system for BPH. Most directly comparable to Mendaera in initial specialty focus (urology) and robotics-based procedural disruption, though addressing different urological indications.

TypeBroad incumbent
Description

Acquired MAKO Surgical and built a dominant orthopedic robotics franchise. As a large incumbent that has successfully commercialized surgical robotics outside Intuitive's core laparoscopic space, Stryker represents both a competitor and potential acquirer for adjacent robotic platforms.

TypeBroad incumbent
Description

Developed the Hugo robotic-assisted surgery platform to compete in laparoscopic surgery. As a diversified medtech incumbent investing heavily in surgical robotics, Medtronic is a relevant peer in the competitive landscape Mendaera is entering.

TypeEmerging player
Description

Emerging surgical robotics company developing a decoupled robotic system for abdominal surgery. Public peer with comparable stage of commercialization challenges and similar mission to bring more accessible robotic surgery to hospitals.

TypeEmerging player
Description

Developer of the Galaxy System, a robotic platform for lung biopsy and other pulmonology procedures. Comparable as a specialty-focused robotic procedural platform combining imaging and robotic guidance to displace freehand clinical workflows.

TypeEmerging player
Description

Developer of the Senhance surgical robotics system with an instrumentation-like, modular form factor. Comparable as a public peer pushing an alternative, lower-cost robotic paradigm against Intuitive's incumbent installed base.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration2 records

Each record includes

Title, Type, Description, Source

AI capability2 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles4 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds3 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors7 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A2 records

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Mendaera

Medical Roboticsmendaera.com

Mendaera is a San Mateo-based healthcare robotics company developing the FDA-cleared Focalist System, a handheld robotic platform combining real-time ultrasound imaging with robotic needle positioning for precise ultrasound-guided needle procedures, sold to hospitals initially targeting urology with planned expansion into interventional radiology and pain management.

What Mendaera does

Mendaera, Inc. is a privately held healthcare technology company founded in 2020 in Silicon Valley and headquartered in San Mateo, California. The company develops the Focalist System, an FDA 510(k)-cleared handheld robotic platform that combines real-time ultrasound imaging with robotic needle positioning and continuous needle depth-tracking to enable precise, reproducible needle placement for ultrasound-guided procedures. The system is positioned to address operator-dependent variability in procedures such as percutaneous nephrolithotomy (PCNL), biopsies, vascular access, and other needle-based interventions, with the stated intent of making precision more accessible across providers with varying skill levels.

Mendaera's commercialization strategy is built around direct enterprise sales to leading medical institutions. The company initiated a limited U.S. launch in 2025 with an initial focus in urology, anchored by early adopters including Mayo Clinic Arizona (where Dr. Karen Stern performed the world's first Focalist procedures) and M Health Fairview. Full commercialization is planned for 2026, with stated expansion into interventional radiology, pain management, and anesthesiology. The company's go-to-market is reinforced by an active presence at industry conferences (AUA, ATC, SUFU, WCET, LSI USA '26, MedTech Insight) and recognition on multiple industry lists (Bessemer Top 50 Physical AI, CB Insights Top 50 Digital Health, Fierce 15, Business Insider Top 12).

The business model combines hardware sales of the Focalist System with recurring instrumentation and disposables (including bundled Cook Medical EchoTip needles) and ongoing service and maintenance through a customer portal. Strategic technology integrations with Butterfly Network (Ultrasound-on-Chip imaging) and EchoNous (image-guided intervention) extend the platform's imaging ecosystem. As of the available data, the company is pre-scaled commercially, having raised approximately $97 million-plus across a 2023 round led by Lux Capital and a 2024 Series B led by Threshold Ventures, with leadership drawn from prior medical robotics exits including Auris Health (acquired by J&J for up to $5.8 billion) and Intuitive Surgical.

Mendaera firmographics

Firmographics
Name
Mendaera
Legal name
Mendaera, Inc.
Website
https://mendaera.com
Company type
Private
Founded year
2020
Operating status
Operating
Headcount range
51–100 employees
Short description
Mendaera is a San Mateo-based healthcare robotics company developing the FDA-cleared Focalist System, a handheld robotic platform combining real-time ultrasound imaging with robotic needle positioning for precise ultrasound-guided needle procedures, sold to hospitals initially targeting urology with planned expansion into interventional radiology and pain management.
Ownership category
akta.pro rank

Mendaera industry classification

Industry
Product category
Medical Robotics
NAICS
Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
SIC
Surgical & Medical Instruments & Apparatus (3841)
akta.pro industry
PRIMARYHLAHADAF
Surgical Robotics & Computer-Assisted Surgery Platforms
Healthcare & Life Sciences/Medical Devices & Diagnostics/Surgical Instruments, Endoscopy & OR Equipment
SECONDARYHLAHADAH
Intraoperative Imaging & Guidance (C-arms, O-arm, IOUS, fluorescence)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Surgical Instruments, Endoscopy & OR Equipment
SECONDARYHLAKAOAF
Endourology & Minimally Invasive Urologic Surgery
SECONDARYHLAHABAG
Interventional Radiology & Image-Guided Therapy Systems
Healthcare & Life Sciences/Medical Devices & Diagnostics/Medical Imaging & Radiology Equipment

Keywords

  • Handheld surgical robotics
  • Ultrasound-guided procedures
  • Medical robotics systems
  • Needle placement devices
  • Robotic imaging platforms

Where Mendaera is headquartered

Location

Headquarters

HQ city
San Mateo
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Mendaera business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Supply Chain, Personnel, Marketing or Sales, Operations, Infrastructure

Revenue model

  1. Focalist System Hardware Sales: Sale of the handheld robotic Focalist System to healthcare institutions. The company is preparing for commercial launch with initial focus on urology.
  2. Instrumentation and Disposables: Sale of compatible needles and instrumentation kits including Cook Medical's EchoTip technology integrated into Mendaera's offerings.
  3. Service and Maintenance: Ongoing service and maintenance services provided through the customer portal for Focalist System users.

Go-to-market motion2 records

Distribution channels1 record

Marketing channels4 records

Mendaera product offering

Product offering

Core offering

Mendaera designs, develops, and sells the Focalist System, a handheld robotic platform that combines real-time ultrasound imaging with robotic needle positioning to enable precise, reproducible needle placement during ultrasound-guided medical procedures. The company also offers compatible instrumentation (including integrated Cook Medical EchoTip needles) and post-sale service, training, and software updates through its customer portal, with initial commercial focus on urology and planned expansion into interventional radiology and pain management.

Product overview

Mendaera offers the Focalist System, a single FDA-cleared handheld robotic platform that combines real-time ultrasound imaging with robotic needle positioning and advanced software. The system is designed to make precision needle-based procedures more accessible across healthcare settings. Mendaera generates revenue through medical device sales and provides配套 services including a customer portal with Instructions for Use, software release notes, maintenance information, and training materials. The company operates strategic partnerships with Butterfly Network (for ultrasound-on-chip technology integrated into the system) and Cook Medical (for bundled EchoTip needles in instrumentation offerings).

Differentiator

Problem solved

Functional benefit

Brands

  • Focalist: Handheld robotic system for needle-based procedures combining real-time ultrasound imaging with robotic control for precise instrument placement during diagnostic and therapeutic procedures.

Products and services

  • Focalist System FDA-cleared handheld robotic system that combines real-time ultrasound imaging with intuitive robotic control and touchscreen targeting to enable precise, reproducible needle placement for ultrasound-guided diagnostic and therapeutic procedures across multiple medical specialties, intended for use with pediatric and adult patients.
  • Focalist Instrumentation and Disposables Compatible needles and instrumentation kits sold alongside the Focalist System, including integrated Cook Medical EchoTip trocar needle technology, bundled to streamline setup and workflow for percutaneous needle-based procedures.
  • Focalist Service, Maintenance, and Customer Portal Ongoing service and maintenance offering delivered through a secure customer portal that provides Instructions for Use, software release notes, service information, training materials, and other support resources for Focalist System users at healthcare institutions.

Quantifiable outcome

  • Precise first-pass needle placement into ideal kidney location during PCNL procedures
  • +1 more outcomes

Companies that use Mendaera

Customer profile

Named customers2 records

Segments3 records

Ideal customer profiles1 record

Mendaera technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration2 records

AI capability2 records

Feature4 records

Mendaera partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered core and major.

  • Cook MedicalcoreStrategic or Co-development Partner · 23 April 2025Collaboration to integrate Cook's EchoTip trocar needle technology with Mendaera's Focalist System for needle-based urological procedures. The partnership aims to create cutting-edge solutions for percutaneous procedures with fit-for-purpose disposables paired with robotics.
  • EchoNousmajorTechnology or Integration · 8 October 2024Partnership to revolutionize image-guided intervention using EchoNous ultrasound technology integrated with Mendaera's robotic platform. Part of Mendaera's strategy to utilize advanced ultrasound-on-chip technology.
  • Butterfly NetworkmajorTechnology or Integration · 1 January 2023Commercial agreement established for use of Butterfly Network's Ultrasound-on-Chip technology in the Focalist System. Mendaera acquired telepresence technology and established this commercial partnership.

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

Mendaera competitors and assessment

Company assessment

Broad incumbents

  • Intuitive Surgical: Market leader in robotic surgery with the da Vinci platform. While its systems are large, expensive, fixed installations focused on laparoscopic surgery, it represents the dominant incumbent Mendaera's leadership team previously competed against and that any handheld robotic entrant must displace or complement.
  • Johnson & Johnson MedTech (Ottava / Auris Health): Acquired Auris Health for up to $5.8B and is developing the Ottava robotic surgery platform. Multiple Mendaera executives (DeFonzo, Davidson, Martinez) came directly from this organization, making J&J both a competitor and the most logical strategic acquirer of Mendaera's handheld platform.
  • Stryker (MAKO Surgical): Acquired MAKO Surgical and built a dominant orthopedic robotics franchise. As a large incumbent that has successfully commercialized surgical robotics outside Intuitive's core laparoscopic space, Stryker represents both a competitor and potential acquirer for adjacent robotic platforms.
  • Medtronic (Hugo Robotic-Assisted Surgery): Developed the Hugo robotic-assisted surgery platform to compete in laparoscopic surgery. As a diversified medtech incumbent investing heavily in surgical robotics, Medtronic is a relevant peer in the competitive landscape Mendaera is entering.

Direct peers

  • CMR Surgical: Developer of the Versius surgical robotic system, a smaller, modular robotic platform competing in laparoscopic surgery. Like Mendaera, CMR is challenging the Intuitive paradigm with a more portable, lower-cost robotic architecture aimed at broader hospital adoption.
  • Moon Surgical: Developer of the Maestro handheld surgical robotics system, conceptually the closest peer to Mendaera. Both companies are pioneering handheld robotic form factors designed to assist surgeons in real-time, rather than full-sized fixed surgical robots.
  • PROCEPT BioRobotics: Commercial-stage robotics company focused on urology with the AquaBeam/Aquablation system for BPH. Most directly comparable to Mendaera in initial specialty focus (urology) and robotics-based procedural disruption, though addressing different urological indications.

Emerging players

  • Vicarious Surgical: Emerging surgical robotics company developing a decoupled robotic system for abdominal surgery. Public peer with comparable stage of commercialization challenges and similar mission to bring more accessible robotic surgery to hospitals.
  • Noah Medical: Developer of the Galaxy System, a robotic platform for lung biopsy and other pulmonology procedures. Comparable as a specialty-focused robotic procedural platform combining imaging and robotic guidance to displace freehand clinical workflows.
  • Asensus Surgical: Developer of the Senhance surgical robotics system with an instrumentation-like, modular form factor. Comparable as a public peer pushing an alternative, lower-cost robotic paradigm against Intuitive's incumbent installed base.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Mendaera social profiles

Digital presence

Mendaera compliance and trust

Trust signal

Compliance1 record

Mendaera financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Mendaera leadership team

Management profile

Number of profiles

Profiles4 records

Mendaera funding detail

Funding detail

Funding overview

Funding rounds3 records

Investors7 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Mendaera M&A and investment

M&A and investment

M&A2 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Mendaera

What does Mendaera do?

Mendaera designs, develops, and sells the Focalist System, a handheld robotic platform that combines real-time ultrasound imaging with robotic needle positioning to enable precise, reproducible needle placement during ultrasound-guided medical procedures. The company also offers compatible instrumentation (including integrated Cook Medical EchoTip needles) and post-sale service, training, and software updates through its customer portal, with initial commercial focus on urology and planned expansion into interventional radiology and pain management.

Is Mendaera a public or private company?

Mendaera is a private company. It is classified as venture growth investor backed and is currently operating.

When was Mendaera founded?

Mendaera was founded in 2020. It employs 51 to 100 people.

Where is Mendaera based?

Mendaera is headquartered in San Mateo, United States, in the North America region.

How does Mendaera make money?

Three revenue lines are on record. Focalist System Hardware Sales are the primary driver. The others are instrumentation and Disposables and service and Maintenance.

Who are Mendaera's main competitors?

Broad incumbents on record are Intuitive Surgical, Johnson & Johnson MedTech (Ottava / Auris Health), Stryker (MAKO Surgical) and Medtronic (Hugo Robotic-Assisted Surgery). Direct peers are CMR Surgical, Moon Surgical and PROCEPT BioRobotics. Emerging players are Vicarious Surgical, Noah Medical and Asensus Surgical.

Does Mendaera have an API?

No public API is recorded for Mendaera.

What industry is Mendaera in?

Mendaera's product category is Medical Robotics. Its primary akta.pro industry code is HLAHADAF, Surgical Robotics & Computer-Assisted Surgery Platforms, with a secondary code of HLAHADAH, Intraoperative Imaging & Guidance (C-arms, O-arm, IOUS, fluorescence). Its NAICS code is 334510 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Business Wire BlogMendaera’s Focalist™ System Now Compatible with Butterfly’s Ultrasound-on-Chip™ TechnologyMendaera's Focalist system is now commercially available with Butterfly Network's Ultrasound-on-Chip imaging technology, marking the first Butterfly Embedded partner to commercialize. The FDA-cleared system combines handheld robotics, real-time imaging, and intelligent guidance for image-guided needle procedures. The companies will exhibit at ACEP26 in October 2026.BioSpaceNew Peer-Reviewed Study Shows 98% Technical Success for Mendaera’s Focalist™ System Across Urology, Anesthesiology, and NephrologyMendaera Inc. announced results from a peer-reviewed study showing its Focalist system achieved technical success in 60 of 61 ultrasound-guided percutaneous procedures with zero device-related adverse events. The study, published in the World Journal of Urology, evaluated the system across urology, nephrology, and anesthesiology after a single 45-minute training session.PR NewswireNew Peer-Reviewed Study Shows 98% Technical Success for Mendaera's Focalist™ System Across Urology, Anesthesiology, and NephrologyMendaera Inc. announced peer-reviewed study results showing that its FDA-cleared Focalist™ system achieved technical success in 60 of 61 ultrasound-guided percutaneous procedures with zero device-related adverse events. The prospective multispecialty study, published in the World Journal of Urology, demonstrated that physicians from urology, nephrology, and anesthesiology could successfully use the handheld robotic system after a single 45-minute training session.openPR.comUS Medical Robotics Market is expected to Hit US$ 286.99 Million by 2033 | Major Companies - Intuitive Surgical, Stryker Corporation, Medtronic Plc, Mendaera, Globus Medical IncDataM Intelligence released a market research report projecting the US Medical Robotics Market will grow from US$63.53 million in 2024 to US$286.99 million by 2033, representing a CAGR of 16.2%. The report identifies key industry drivers including AI integration in surgical robotics, expansion of robotic-assisted orthopedic procedures, and increasing hospital adoption of autonomous workflow automation. Recent merger and acquisition activity underscores strategic consolidation, with Medtronic completing two acquisitions (Scientia Vascular for $550 million and CathWorks for $585 million) and Danaher announcing the acquisition of Masimo for approximately $9.9 billion.openPR.comLeading Companies Advancing Innovation and Growth in the Robotic Ultrasound Systems MarketThe robotic ultrasound systems market is projected to grow to $3.77 billion by 2030 with a compound annual growth rate of 16.2%, driven by remote healthcare expansion, AI adoption, and automation in hospital workflows. In December 2023, Butterfly Network Inc. formed a commercial partnership with Mendaera Inc. to integrate its Ultrasound-on-Chip technology into Mendaera's interventional robotic system, while in May 2025 Denmark-based Life Science Robotics launched ARUS, a robotic arm-based ultrasound device with haptic feedback and adaptive pressure management.Business Wire BlogMendaera Receives FDA 510(k) Clearance for Handheld Robotic SystemMendaera, Inc. has received FDA 510(k) clearance for its Focalist™ System, a handheld robotic device designed to enhance precision in ultrasound-guided needle placement procedures. The company plans to initiate a limited launch with select medical institutions focusing on urology in 2025, aiming for full commercialization in 2026.LivhospitalSurgical Robots: Who is the Leading and Amazing Manufacturer?This industry analysis article examines the competitive landscape of the global surgical robotics market, where Intuitive Surgical dominates with approximately 70% market share through its da Vinci Surgical System, while competitors Medtronic (15%) and Johnson & Johnson (10%) are actively developing rival platforms. The article reports that over 6 million robotic surgical procedures have been performed globally, with the market expanding across regional segments including North America ($1.2B at 12% growth), Europe ($800M at 10% growth), and Asia-Pacific ($500M at 15% growth). Emerging players like Mendaera and Cobalt Robotics are bringing AI-driven and specialized solutions to the market, while industry leaders are investing in innovations including artificial intelligence integration, haptic feedback technology, and single-port miniaturized systems to address technical limitations and drive further adoption.openPR.comUnited States Medical Robotics Market Accelerates with Cutting-Edge Innovations and Rising Healthcare Investments 2025 | Top key players - Medtronic Plc, Mendaera, Zimmer Biomet Holdings, Inc.The US medical robotics market is projected to grow from $63.53 million in 2024 to $286.99 million by 2033, a CAGR of 16.2%. Recent developments include FDA clearance of Microbot Medical's Liberty system, AI integration, and Zimmer Biomet's acquisition of Monogram Technologies.Consegic Business IntelligenceTelepresence Robots Market Size, Trends, Future Growth & Share Forecast 2032A market research report forecasts the global telepresence robots market to reach over USD 1,349.71 Million by 2032, growing at a CAGR of 19.0% from 2025 to 2032. Key growth drivers include improved connectivity, AI integration, and increasing adoption in healthcare and education sectors, while data privacy concerns remain a restraint. The report highlights significant activity among key players such as Mendaera Inc., Symbotic Inc., OhmniLabs, and Ava Robotics through acquisitions, funding, and partnerships.Robotics & Automation NewsMendaera receives FDA clearance for handheld robotic system for ultrasound-guided needle placementMendaera received FDA 510(k) clearance for its handheld robotic system Focalist, designed for ultrasound-guided needle placement. The company will launch with select institutions in 2025, focusing on urology, with full commercialization expected in 2026.